Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Clinical trials paired semaglutide with reduced-calorie diets (approximately 500 calories below maintenance) and 150 minutes of weekly physical activity
Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: A systematic review and meta-analysis
Things to Keep in Mind Wegovy is preferred on most Aetna plans CVS Caremark made it their primary GLP-1 in July 2025 Prior authorization is required you'll need to meet BMI and documentation criteria If denied, file an appeal 65%+ of appealed denials are overturned when properly documented [5] Cardiovascular benefit strengthens your case Wegovy is FDA-approved to reduce heart attack/stroke risk (March 2024) If your PA is denied, don't give up most denials can be overturned with the right documentation
Pills are also easier to manufacture than injectable pens, which could help avoid the frustrating supply problems that slowed earlier GLP-1 launches
FGF, Fibroblast growth factor
US$ 27.14
US$ 24.89
US$ 29.95
US$ 27.01
US$ 21.30
US$ 24.16
US$ 28.67
US$ 27.92
US$ 23.64
